CHICAGO, June 7, 2024 /PRNewswire/ — The autologous stem cell and non-stem cell therapies market is set to grow significantly, with estimates suggesting a rise to $22.2 billion by 2029 from $5.5 billion in 2024, indicating a CAGR of 32.3%. This growth is fueled by regulatory approvals…